1. Home
  2. TSAT vs NBP Comparison

TSAT vs NBP Comparison

Compare TSAT & NBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Telesat Corporation

TSAT

Telesat Corporation

HOLD

Current Price

$50.70

Market Cap

697.5M

Sector

Industrials

ML Signal

HOLD

NBP

NovaBridge Biosciences American Depositary Shares

N/A

Current Price

$2.70

Market Cap

379.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TSAT
NBP
Founded
1969
2014
Country
Canada
United States
Employees
711
32
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
697.5M
379.3M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
TSAT
NBP
Price
$50.70
$2.70
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
$37.00
$9.00
AVG Volume (30 Days)
172.2K
860.5K
Earning Date
05-05-2026
04-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.81
$2.10
52 Week High
$47.90
$5.19

Technical Indicators

Market Signals
Indicator
TSAT
NBP
Relative Strength Index (RSI) 71.13 49.72
Support Level $22.04 $2.19
Resistance Level N/A $3.80
Average True Range (ATR) 3.55 0.21
MACD 0.74 0.05
Stochastic Oscillator 94.13 83.09

Price Performance

Historical Comparison
TSAT
NBP

About TSAT Telesat Corporation

Telesat Corp is a satellite operator, that provides its customers with mission-critical communications services. It operates in a single operating segment, in which it provides satellite-based services to its broadcast, enterprise, and consulting customers around the world. The company has two operating segments: GEO services (GEO) segment that refers to the operation of the fleet of GEO satellite and LEO services (LEO) segment that refers to the deployment and operation of the Telesat Lightspeed constellation Geographically, it derives a majority of its revenue from Canada. It derives revenue from Broadcast, Enterprise, Consulting, and others.

About NBP NovaBridge Biosciences American Depositary Shares

NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. It integrates scientific discovery with strategic planning and project management to move therapies from research toward potential patient use. Its pipeline includes Givastomig, VIS-101, Ragistomig and Uliledlimab.

Share on Social Networks: